Jipeng Wang

Responsible for market positioning, product strategy, and sales management Business: Drive sales winrate growth (20% in 2023 → 25% in 2024 → 27% in 2025) and brand reputation enhancement; collaborate with associations and marketing team to pre-deploy new product solutions and improve NPI meeting quality in a holistic manner. Market: Establish strategic partnerships with 3 major associations in China; launch collaborations with the National Health Commission, Translational Medicine Centers, Official Media and GCP to empower business development. Clients: Resolve client issues and pain points; fully improve KOL satisfaction in Level 3 hospitals; deliver cooperation solutions and built showsites. Team: Enable differentiated development of team members; enhance overall team combat capability; deepen the business closed-loop of client terminals, channels, and sales. Projects: Lead cross-departmental flagship projects (AD industry-academia-research cooperation, CT experts consensus, National Health Commission Medical Workers’Union, expanding business dimensions)

Responsible for full-line sales and cooperation with top hospitals. (Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Cancer Hospital and China-Japan Friendship Hospital) Performance: Annual Order > 7Million; Annual Sales > 7Million; drive winrate from 0 to 70%, lead leapfrog growth during tenure. Clients: Build excellent sales, trust, and cooperation foundations with major associations, hospital leaders, and KOLs across all clinical departments. Market: Establish integrated cooperation platforms (precision management, research, conferences, translational medicine); possess experience in National Health Commission collaboration and centralized procurement. Projects: Launch the first Translational Medicine One MI Project(nuclear medicine department), national CT showsite for Radiation Therapy, national alliance for hybrid operating rooms; build business benchmarks from scratch, deliver academic/technical influence and establish MAB model across multiple disciplines.

Responsible for interventional product projects in all public hospitals in Hubei Performance: Achieve zero-breakthrough in Yichang; develop 2 showsites, 1 KOL and 8 channel learning platforms. Market: Host 2 product launch events (attendance >200) and 6 new technology seminars; build regional influence for NPI. Projects: Establish sales tools library; build standard hospital model to analyze potential clients; member of Commercial Leadership Program.